Elfin Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.96 M
as on 15-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.15 Cr
as on 15-12-2024
- Satisfied Charges ₹ 17.23 Cr
as on 15-12-2024
- Revenue 86.82%
(FY 2023)
- Profit 111.26%
(FY 2023)
- Ebitda -321.43%
(FY 2023)
- Net Worth 13.00%
(FY 2023)
- Total Assets -5.39%
(FY 2023)
About Elfin Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.96 M.
The company currently has active open charges totaling ₹7.15 Cr. The company has closed loans amounting to ₹17.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gurinder Makkar, Manpreet Kaur, and Dilpreet Singh serve as directors at the Company.
- CIN/LLPIN
U24231PB1999PTC022779
- Company No.
022779
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
- Social Media
What products or services does Elfin Pharma Private Limited offer?
Elfin Pharma Private Limited offers a wide range of products and services, including Anti Inflammatory Drugs, Allopathic Cough Syrup, Anti Cold Syrup, Antibacterial Drugs, Antibiotic Medicine, Nutraceuticals & Dietary Supplements, Dietary Supplements, Digestive System Drugs & Medicines, Antacid Drugs, Malaria Medicine.
Who are the key members and board of directors at Elfin Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilpreet Singh  | Managing Director | 15-Feb-2001 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurinder Makkar | Director | 28-Apr-2004 | Current |
| Manpreet Kaur | Whole-Time Director | 15-Feb-2001 | Current |
Financial Performance of Elfin Pharma.
Elfin Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.82% increase. The company also saw a substantial improvement in profitability, with a 111.26% increase in profit. The company's net worth Soared by an impressive increase of 13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elfin Pharma?
In 2023, Elfin Pharma had a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karur Vysya Bank Limited Creation Date: 09 Jul 2012 | ₹1.20 M | Open |
Oriental Bank Of Commerce Creation Date: 21 Feb 2006 | ₹5.54 Cr | Open |
State Bank Of Patala Creation Date: 27 Nov 2002 | ₹6.50 M | Open |
How Many Employees Work at Elfin Pharma?
Elfin Pharma has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elfin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elfin Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
